Price target
Based on analysts projections #CYTK is expected to experience a positive growth trajectory over the next year.
The current average CYTK price target, as estimated by these analysts, is $60.71.
The predictions for the future CYTK stock price range from a low of $45.00 to a high of $75.00, highlighting the variability of market expectations for CYTK.
It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.
CYTK stock forecasts by analyst
| Analyst / firm | Date | Rating | Price target | Price when posted |
|---|---|---|---|---|
| Needham | December 23, 2022 | Buy | 58.00 | 45.59 |
| Truist Financial | December 20, 2022 | Buy | 60.00 | 45.22 |
|
Dane Leone Raymond James |
August 23, 2022 | Buy | 63.00 | 52.17 |
|
Yasmeen Rahimi Piper Sandler |
June 9, 2022 | Buy | 72.00 | 38.84 |
|
Joseph Pantginis H.C. Wainwright |
April 30, 2022 | Buy | 75.00 | 39.87 |
|
Carter Gould Barclays |
December 20, 2021 | Buy | 52.00 | 39.50 |
|
Dane Leone Raymond James |
November 18, 2021 | Buy | 54.00 | 40.73 |
|
Jeffrey Hung Morgan Stanley |
October 8, 2021 | Buy | 45.00 | 38.01 |
Cytokinetics, (CYTK) Fundamentals Checker
Financial metrics are used to evaluate financial stability which helps analysts determine if Cytokinetics, is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.
Neutral
Financial Scores
Updated on: 07/12/2023
Altman Z-Score: -3.5
Piotroski Score: 1.0
ESG Score
Updated on: 07/12/2023
Environmental: 53.4
Social: 64.6
Governance: 60.6
Financial Health
Updated on: 07/12/2023
DCF: Strong Buy
ROE: Strong Buy
ROA: Sell
Debt to equity ratio: Strong Sell
Price to earnings ratio: Strong Sell
Price to book ratio: Strong Sell
CYTK Discounted Cash Flow
Updated on: 07/12/2023
$34.863
Discounted Cash Flow Value
$33.460
Current Price
CYTK Revenues by Segment
Updated on: 07/12/2023
Revenue from Contract with Customer, Excluding Assessed Tax
CYTK Revenues by Region
Updated on: 07/12/2023
No available data
CYTK Notes Due
Updated on: 07/12/2023
| CIK | Exchange | Title |
|---|
There are no data to display
No social results for CYTK
Cytokinetics Stock Forecast: A Promising Future for a Leading Biopharmaceutical Company
Cytokinetics, Inc., a biopharmaceutical company operating in the United States, engages in the discovery, research, and development of muscle activators and inhibitors. With its stock ticker CYTK listed on various stock exchanges such as NASDAQ GS, over the years, the company has emerged as a leading player in its field. In this article today, we'll discuss Cytokinetics' outlook with respect... Read more
Prospects of Biotechnology Stock Prediction: The Case of Cytokinetics
The biotechnology sector has been one of the most promising areas for investment in recent years. With groundbreaking advancements in treatments and cures for various diseases, investors are eyeing the biotech market with anticipation. Companies like Cytokinetics, with stock ticker Biotechnology, are at the forefront of this innovative field. Cytokinetics is a biopharmaceutical company focused on developing muscle activators and...
It's important to note that investing in biotechnology stocks is not without risk. As cutting-edge research continues to push boundaries and uncover new treatment options, companies may face setbacks or delays that could impact their financial performance.
However, with bold innovations like those being pursued by Cytokinetics and other leading companies in the field, many investors believe that now is an exciting time to invest in biotech stocks. By staying informed on clinical trials progress and market trends along with analyzing historical data it’s possible to make informed judgements while making Biotechnology stock predictions.
Overall, the biotechnology sector offers exciting opportunities for long-term growth if approached wisely through educated share value predictions. As one of its prominent players within it; Cytokinetics BioTechnology has definitely attracted investor appeal and signals being on track for future success.">Read more
It's important to note that investing in biotechnology stocks is not without risk. As cutting-edge research continues to push boundaries and uncover new treatment options, companies may face setbacks or delays that could impact their financial performance.
However, with bold innovations like those being pursued by Cytokinetics and other leading companies in the field, many investors believe that now is an exciting time to invest in biotech stocks. By staying informed on clinical trials progress and market trends along with analyzing historical data it’s possible to make informed judgements while making Biotechnology stock predictions.
Overall, the biotechnology sector offers exciting opportunities for long-term growth if approached wisely through educated share value predictions. As one of its prominent players within it; Cytokinetics BioTechnology has definitely attracted investor appeal and signals being on track for future success.">Read more
Cytokinetics, (CYTK) Social Sentiments
Monitoring bullish and bearish sentiments towards Cytokinetics, on Twitter and Stocktwits could help to forecast an upward or downward trend in Cytokinetics, stock price.